Beacon Therapeutics presented 3-month interim safety and efficacy data from the Phase 2 DAWN trial of laru-zova (AGTC-501) for X-linked retinitis pigmentosa (XLRP) at the FLORetina ICOOR 2024 meeting in Florence, Italy.According to the company, the data show early promise in improving low luminance visual acuity (LLVA), a key measure of visual function in patients with this … [Read more...] about Beacon Therapeutics announces positive 3-month data from Phase 2 DAWN trial of AGTC-501 in patients with X-linked retinitis pigmentosa
News
ARCHER trial shows benefit of ANX007 on vision loss in geographic atrophy
December 09, 2024 1 min read BARCELONA, Spain — In the phase 2 ARCHER trial, ANX007, a novel C1q inhibitor with neuroprotective properties, showed consistent protection against loss of visual acuity in eyes with geographic atrophy. One-year study results as well as 18-month extension data were presented by Usha Chakravarthy, MD, PhD, at the … [Read more...] about ARCHER trial shows benefit of ANX007 on vision loss in geographic atrophy
Corneal dome lens enhances visualization of ocular surface
December 09, 2024 1 min read BARCELONA, Spain — A dome-shaped lens design integrated in a novel ocular surface imaging system provides a complete view of the cornea, conjunctiva, sclera and lid margins, allowing for precise detection of abnormalities. Ordinary slit lamp lenses can produce the bokeh effect, Vito Romano, MD, said at the … [Read more...] about Corneal dome lens enhances visualization of ocular surface
VIDEO: Courses focus on vitreous management, MIGS for anterior segment surgeons
December 09, 2024 4 min watch CHICAGO — In this Healio Video Perspective from the AAO meeting, Vikas Chopra, MD, discusses vitreous management for the anterior segment surgeon. “The reason this is important is because vitreous loss is a very uncommon complication of cataract surgery but certainly a very important one,” he said. “One of the … [Read more...] about VIDEO: Courses focus on vitreous management, MIGS for anterior segment surgeons
New study highlights retinopathy risk from hair dye use
A recent French study reported that aromatic amines in hair dye are associated with the development of retinopathy,1 according to Nicolas Chirpaz, MD, first author, from the Ophthalmology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.Chirpaz and colleagues described the presence of multiple bilateral serous retinal detachments (SRDs) found ian 3 … [Read more...] about New study highlights retinopathy risk from hair dye use
Study finds increased air pollution leads to surge in daily eye clinic visits
The number of daily patient visits at the Sue Anschutz-Rodgers Eye Center significantly rise when ambient particulate matter (PM) levels in the Denver metro region increase, according to a study conducted by ophthalmology researchers at the University of Colorado School of Medicine.The research team noted the World Health Organization has declared climate change to be “the … [Read more...] about Study finds increased air pollution leads to surge in daily eye clinic visits
Generative AI: It’s only just begun
Artificial intelligence (AI) may someday be a valuable asset in medical practice by achieving equivalency with medical experts, but that time has not yet arrived in the cornea subspecialty, according to a recent study evaluating AI’s performance in cataract, cornea, and refractive surgery clinical scenarios.ChatGPT 4.0 demonstrated suboptimal absolute agreement with expert … [Read more...] about Generative AI: It’s only just begun
Comparison of different treatment options in submacular haemorrhage
Submacular haemorrhages (SMH) cause significant visual impairment. Until now, the comparative effectiveness of different treatment approaches remains inconclusive without clear treatment guidelines. The aim of... … [Read more...] about Comparison of different treatment options in submacular haemorrhage
VIDEO: Pass-through reimbursement changes coming in 2025
December 08, 2024 1 min watch NEW YORK — In this Healio Video Perspective from OSN New York, John A. Hovanesian, MD, FACS, discusses an update on pass-through reimbursement. Hovanesian said a CMS ruling that goes into effect in January 2025 will allow hospital outpatient department surgery to use products such as Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular … [Read more...] about VIDEO: Pass-through reimbursement changes coming in 2025
Part 6: Advice from the experts: Helpful information for current residents
In this series, experts in the field advise current residents and offer insight into how they can make the most of their time and experience moving forward with their careers.Video Transcript:Editor's note: The below transcript has been lightly edited for clarity.Fatemah Rajaii, MD, PhD:So I think one thing is to remember to have a high index of suspicion for thyroid eye … [Read more...] about Part 6: Advice from the experts: Helpful information for current residents